UNSPSC 51203400: Immunosupressant purines

This classification denotes heterocyclic pyrimidine-imidazole ring compounds present in many alkaloids and nucleic acids, substances called purines, that reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT PURINES.

UNSPSC 51203400 Immunosuppressant purines, a Class code, does not reflect the work actually being solicited under this classification in recent state and local procurement activity. The code's nominal scope—immunosuppressant purine drugs—diverges sharply from the diverse emergency medical, pharmacy benefit, and pharmaceutical supply work appearing in recent solicitations posted under this code. State and local buyers posting opportunities here are procuring naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing agreements, medical and first aid supplies for emergency response divisions, and exploring direct-to-manufacturer pharmacy benefit programs. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). This pattern suggests either miscoding at the point of solicitation or a mismatch between the code's definition and how procurement offices are tagging emergency medical and pharmaceutical supply purchases.

Recent opportunities show geographic spread across Florida, Texas, Minnesota, and Oregon, though the concentration reflects only the handful of posted notices rather than sustained activity. Representative recent solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually; the City of Tampa's competitive bid 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies totaling approximately $700,000 and designated as a sheltered market opportunity for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products through authorized wholesalers. The Texas HHS Commission also issued RFI HHS0017013 (posted April 3, 2026; due April 3, 2026) to gather vendor capabilities regarding direct-to-manufacturer prescription programs. The code shows little relevant recent activity aligned with its stated scope; verify coding accuracy before pursuing opportunities posted under this classification.